Paul M Silva insider trades: Rapport Therapeutics (RAPP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
108 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | RAPP | ↑ Buy | 3,680 | $27.07 | $100K | By Paul M Silva 2016 Declaration of Trus | Oct 22, 2026 (0d) |
| Mar 1, 2021 | VRTX | ↓ Sell | 2,782 | $211.45 | $588K | Direct | Mar 2, 2021 (1d) |
| Feb 25, 2021 | VRTX | ↓ Sell | 1,080 | $213.47 | $231K | Direct | Feb 26, 2021 (1d) |
| Feb 18, 2021 | VRTX | ↓ Sell | 4,295 | $211.83 | $910K | Direct | Feb 19, 2021 (1d) |
| Feb 11, 2021 | VRTX | ↓ Sell | 1,498 | $210.57 | $315K | Direct | Feb 16, 2021 (5d) |
| Aug 6, 2020 | VRTX | ↓ Sell | 1,078 | $271.17 | $292K | Direct | Aug 10, 2020 (4d) |
| Aug 3, 2020 | VRTX | ↓ Sell | 809 | $278.30 | $225K | Direct | Aug 5, 2020 (2d) |
| Jul 13, 2020 | VRTX | ↓ Sell | 860 | $292.03 | $251K | Direct | Jul 15, 2020 (2d) |
| May 15, 2020 | VRTX | ↓ Sell | 151 | $284.00 | $43K | Direct | May 19, 2020 (4d) |
| May 6, 2020 | VRTX | ↓ Sell | 1,076 | $272.74 | $293K | Direct | May 8, 2020 (2d) |
| May 4, 2020 | VRTX | ↓ Sell | 809 | $260.87 | $211K | Direct | May 6, 2020 (2d) |
| Apr 13, 2020 | VRTX | ↓ Sell | 859 | $248.72 | $214K | Direct | Apr 15, 2020 (2d) |
| Apr 6, 2020 | VRTX | ↓ Sell | 4,891 | $255.57 | $1.2M | Direct | Apr 8, 2020 (2d) |
| Feb 25, 2020 | VRTX | ↓ Sell | 1,080 | $233.45 | $252K | Direct | Feb 26, 2020 (1d) |
| Feb 18, 2020 | VRTX | ↓ Sell | 1,564 | $243.58 | $381K | Direct | Feb 19, 2020 (1d) |
| Feb 11, 2020 | VRTX | ↓ Sell | 5,862 | $246.04 | $1.4M | Direct | Feb 12, 2020 (1d) |
| Feb 6, 2020 | VRTX | ↓ Sell | 466 | $239.32 | $112K | Direct | Feb 7, 2020 (1d) |
| Feb 3, 2020 | VRTX | ↓ Sell | 2,099 | $231.03 | $485K | Direct | Feb 5, 2020 (2d) |
| Jan 31, 2020 | VRTX | ↓ Sell | 1,396 | $238.65 | $333K | Direct | Feb 4, 2020 (4d) |
| Jan 13, 2020 | VRTX | ↓ Sell | 860 | $229.38 | $197K | Direct | Jan 15, 2020 (2d) |
| Jan 8, 2020 | VRTX | ↓ Sell | 13,750 | $231.89 | $3.2M | Direct | Jan 10, 2020 (2d) |
| Jan 2, 2020 | VRTX | ↓ Sell | 25,630 | $218.92 | $5.6M | Direct | Jan 6, 2020 (4d) |
| May 15, 2019 | VRTX | ↓ Sell | 161 | $165.41 | $27K | Direct | May 17, 2019 (2d) |
| Feb 19, 2019 | VRTX | ↓ Sell | 2,812 | $186.97 | $526K | Direct | Feb 21, 2019 (2d) |
| Feb 11, 2019 | VRTX | ↓ Sell | 4,215 | $180.16 | $759K | Direct | Feb 13, 2019 (2d) |
| Feb 6, 2019 | VRTX | ↓ Sell | 1,289 | $193.00 | $249K | Direct | Feb 7, 2019 (1d) |
| Feb 4, 2019 | VRTX | ↓ Sell | 4,247 | $187.02 | $794K | Direct | Feb 6, 2019 (2d) |
| Jan 17, 2019 | VRTX | ↓ Sell | 2,148 | $190.75 | $410K | Direct | Jan 18, 2019 (1d) |
| Dec 3, 2018 | VRTX | ↓ Sell | 809 | $186.52 | $151K | Direct | Dec 4, 2018 (1d) |
| Nov 15, 2018 | VRTX | ↓ Sell | 12 | $163.75 | $2K | Direct | Nov 19, 2018 (4d) |
| Aug 3, 2018 | VRTX | ↓ Sell | 2,098 | $174.44 | $366K | Direct | Aug 6, 2018 (3d) |
| Jul 16, 2018 | VRTX | ↓ Sell | 860 | $179.85 | $155K | Direct | Jul 18, 2018 (2d) |
| Jul 12, 2018 | VRTX | ↓ Sell | 860 | $175.02 | $151K | Direct | Jul 16, 2018 (4d) |
| Jun 29, 2018 | VRTX | ↓ Sell | 2,957 | $166.52 | $492K | Direct | Jul 3, 2018 (4d) |
| May 15, 2018 | VRTX | ↓ Sell | 201 | $155.78 | $31K | Direct | May 16, 2018 (1d) |
| Apr 18, 2018 | VRTX | ↓ Sell | 859 | $166.05 | $143K | Direct | Apr 19, 2018 (1d) |
| Apr 2, 2018 | VRTX | ↓ Sell | 3,438 | $161.21 | $554K | Direct | Apr 4, 2018 (2d) |
| Feb 20, 2018 | VRTX | ↓ Sell | 3,437 | $158.49 | $545K | Direct | Feb 21, 2018 (1d) |
| Feb 12, 2018 | VRTX | ↓ Sell | 4,213 | $153.41 | $646K | Direct | Feb 14, 2018 (2d) |
| Feb 5, 2018 | VRTX | ↓ Sell | 2,098 | $163.08 | $342K | Direct | Feb 7, 2018 (2d) |
| Feb 2, 2018 | VRTX | ↓ Sell | 9,883 | $173.50 | $1.7M | Direct | Feb 5, 2018 (3d) |
| Jan 23, 2018 | VRTX | ↓ Sell | 5,435 | $164.03 | $891K | Direct | Jan 24, 2018 (1d) |
| Dec 27, 2017 | VRTX | ↓ Sell | 1,289 | $152.31 | $196K | Direct | Dec 28, 2017 (1d) |
| Nov 15, 2017 | VRTX | ↓ Sell | 23 | $147.29 | $3K | Direct | Nov 17, 2017 (2d) |
| Aug 7, 2017 | VRTX | ↓ Sell | 1,289 | $152.88 | $197K | Direct | Aug 9, 2017 (2d) |
| Aug 2, 2017 | VRTX | ↓ Sell | 1,289 | $151.80 | $196K | Direct | Aug 4, 2017 (2d) |
| Jul 31, 2017 | VRTX | ↓ Sell | 860 | $152.99 | $132K | Direct | Aug 2, 2017 (2d) |
| Jul 21, 2017 | VRTX | ↓ Sell | 43,443 | $161.07 | $7.0M | Direct | Jul 21, 2017 (0d) |
| Jun 21, 2017 | VRTX | ↓ Sell | 2,577 | $133.36 | $344K | Direct | Jun 23, 2017 (2d) |
| Jun 1, 2017 | VRTX | ↓ Sell | 3,867 | $127.31 | $492K | Direct | Jun 5, 2017 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RAPP insiders
Open-market trades in the last 12 months
About Paul M Silva's insider trades
Paul M Silva is an insider at Rapport Therapeutics (RAPP). Since Nov 18, 2008, Paul has reported 1 open-market purchase worth $100K and 107 sales worth $50.9M on SEC Form 4. In the last 12 months: 1 buy ($100K).
1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (63 filings), grants and awards (31 filings), shares withheld for taxes (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RAPP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.